Budapest, Hungary

Andras Feher

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Gyogyszerkutato Intezet Kft.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andras Feher. Retrieved from https://idiyas.com/inventor/andras-feher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 15.9

ph-index = 1


Company Filing History:


Years Active: 1998-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andras Feher

Introduction

Andras Feher is a distinguished inventor based in Budapest, Hungary. With a focus on groundbreaking advancements in the field of pharmaceuticals, he has secured two patents that reflect his commitment to innovation and healthcare improvement.

Latest Patents

Andras Feher’s recent inventions include:

1. **Anticoagulant Peptide Aldehyde Derivatives**

2. **Anticoagulant Peptide Derivatives and Pharmaceutical Compositions**

These patents showcase his expertise in developing novel compounds that can potentially enhance anticoagulant therapies.

Career Highlights

Feher is associated with Gyógyszerkutató Intézet Kft., a company dedicated to pharmaceutical research and development. His work at this institution reinforces the importance of scientific innovation in the healthcare sector and contributes significantly to advancements in medical treatments.

Collaborations

Andras Feher collaborates with prominent colleagues such as Sandor Bajusz and Attila Juhasz. Their teamwork fosters a creative environment that encourages the sharing of ideas and the initiation of new research projects.

Conclusion

In conclusion, Andras Feher’s contributions to the field of pharmaceutical research are noteworthy. His patents not only highlight his inventiveness but also promise to impact future medical therapies significantly. Through collaborations with skilled professionals, he continues to strive for advancements that enhance health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…